# Latest EU Assessment on the Safety of Carbon Dioxide Extract from Cannabis sativa L. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/carbon-dioxide-extract-cannabis-safety-eu-assessment/ > **Published:** 2026-04-07T07:03:25-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:28:32-04:00 > **Clinical Summary:** Explore the latest EU assessment on carbon dioxide extract cannabis safety and its impact on medical cannabis product quality and regulation. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic RegulationProduct QualityCo2 ExtractionFood SafetyEu Policy Why This Matters The EU’s ongoing uncertainty about CO2-extracted cannabis as a novel food ingredient directly impacts clinical dosing reliability and product standardization that physicians depend on for consistent therapeutic outcomes. This regulatory limbo affects the quality control standards that differentiate medical-grade cannabis products from inconsistent consumer offerings. Clinical Summary The European Food Safety Authority continues to withhold approval for carbon dioxide-extracted cannabis as a novel food ingredient, citing insufficient safety data despite CO2 extraction being widely considered the cleanest solvent-free method for cannabis concentrate production. This regulatory stance reflects the broader challenge of establishing safety profiles for cannabis-derived ingredients in food applications, where exposure patterns and dosing differ significantly from pharmaceutical preparations. The decision impacts the legal framework for cannabis-containing food products across EU member states. Dr. Caplan’s Take “This EU caution reinforces what I tell patients daily: not all cannabis products are created equal, and regulatory approval gaps often mean we’re working with therapeutically inconsistent materials. The distinction between pharmaceutical-grade preparations and food-grade extracts matters enormously for reproducible clinical outcomes.” Clinical Perspective 🧠 Clinicians should distinguish between pharmaceutical-grade cannabis preparations used in medical practice and food-grade extracts subject to different regulatory standards. Patients using cannabis therapeutically should prioritize products with established quality control and consistent cannabinoid profiles rather than relying on food-grade cannabis products with variable oversight. This regulatory uncertainty underscores the importance of working with medical-grade products when treating specific conditions. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Latest%20EU%20Assessment%3A%20The%20safety%20of%20carbon%20dioxide%20extract%20from%20Cannabis%20sativa%20...%20%40drcaplan&url=http%3A//www.cirs-group.com/en/food/latest-eu-assessment-the-safety-of-carbon-dioxide-extract-from-cannabis-sativa-l-as-a-novel-food-remains-uncertain-and-has-not-yet-been-approved)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=http%3A//www.cirs-group.com/en/food/latest-eu-assessment-the-safety-of-carbon-dioxide-extract-from-cannabis-sativa-l-as-a-novel-food-remains-uncertain-and-has-not-yet-been-approved)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Latest%20EU%20Assessment%3A%20The%20safety%20of%20carbon%20dioxide%20extract%20from%20Cannabis%20sativa%20...%20--%20via%20%40drcaplan.bsky.social%20http%3A//www.cirs-group.com/en/food/latest-eu-assessment-the-safety-of-carbon-dioxide-extract-from-cannabis-sativa-l-as-a-novel-food-remains-uncertain-and-has-not-yet-been-approved)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [http://www.cirs-group.com/en/food/latest-eu-assessment-the-safety-of-carbon-dioxide-extract-from-cannabis-sativa-l-as-a-novel-food-remains-uncertain-and-has-not-yet-been-approved](http://www.cirs-group.com/en/food/latest-eu-assessment-the-safety-of-carbon-dioxide-extract-from-cannabis-sativa-l-as-a-novel-food-remains-uncertain-and-has-not-yet-been-approved) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis news?](#What_is_the_clinical_relevance_rating_for_this_cannabis_news) - [What are the main topic areas covered in this cannabis regulation news?](#What_are_the_main_topic_areas_covered_in_this_cannabis_regulation_news) - [Why is CO2 extraction mentioned as a significant topic?](#Why_is_CO2_extraction_mentioned_as_a_significant_topic) - [How does this news relate to food safety in cannabis products?](#How_does_this_news_relate_to_food_safety_in_cannabis_products) - [What makes this cannabis news worthy of clinical attention?](#What_makes_this_cannabis_news_worthy_of_clinical_attention) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis news? This article has received a CED Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This means the content contains emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What are the main topic areas covered in this cannabis regulation news? The article focuses on four key areas: regulation, product quality, CO2 extraction methods, and food safety standards. These topics are particularly relevant for understanding current [cannabis industry standards](https://cedclinic.com/medical-marijuana-ethics-patient-care-trust/) and safety protocols. #### Why is CO2 extraction mentioned as a significant topic? CO2 extraction is highlighted because it’s considered one of the cleanest and most efficient methods for producing cannabis extracts. This extraction method is often preferred for [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/) due to its ability to preserve cannabinoids while avoiding harmful solvents. #### How does this news relate to food safety in cannabis products? The inclusion of food safety as a key topic suggests the article discusses standards and regulations for [cannabis edibles](https://cedclinic.com/decarboxylating-cannabis-process-why-how/) or consumable products. This is crucial for patient safety and product consistency in the [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) market. #### What makes this cannabis news worthy of clinical attention? The “Notable Clinical Interest” rating indicates this news contains developments that could impact [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) practice or [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/). Healthcare providers should monitor these regulatory and quality control updates to stay informed about evolving standards in medical cannabis. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [EU continues CBD scrutiny, rejecting 6 more novel food applications – NutraIngredients.com](https://cedclinic.com/cbd-regulatory-uncertainty-eu-novel-food-applications/) An update on the EU's ongoing scrutiny of CBD and novel food applications, highlighting regulatory challenges for cannabis-derived products. [Read More](https://cedclinic.com/cbd-regulatory-uncertainty-eu-novel-food-applications/) [Medical Cannabis Commission approves cultivators, but manufacturer process remains unclear](https://cedclinic.com/2026-cannabis-manufacturing-standards-patient-safety/) Insights into regulatory approvals for medical cannabis cultivators and the complexities faced by manufacturers in compliance. [Explore Details](https://cedclinic.com/2026-cannabis-manufacturing-standards-patient-safety/) [Texas hemp industry hopeful to continue operation amid pause on THC ban](https://cedclinic.com/texas-hemp-industry-regulation-operational-pause/) Coverage of the Texas hemp industry's response to regulatory pauses and implications for product safety and market stability. [Learn More](https://cedclinic.com/texas-hemp-industry-regulation-operational-pause/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).